Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23630950 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal
Condition: Hypertension
Interventions: Drug: Aliskiren;   Drug: Telmisartan;   Drug: Placebo to Aliskiren;   Drug: Placebo to Telmisartan

Indicates status has not been verified in more than two years